Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
SubioMed is a private U.S. medical device company focused on biomechanics-based products intended to improve gait, balance, pain, and recovery in people with lower-extremity dysfunction. Its core technology, Suspension Biomechanics, is a patented platform designed to manage ground reaction forces and provide controlled motion during walking. The company appears to be developing and commercializing orthotic and related foot-and-ankle products for both medical and consumer applications, including use with casts, braces, inserts, and footwear-integrated designs. SubioMed positions its technology as a way to reduce pain, improve function, and potentially help prevent or manage lower-extremity pathologies. It is best characterized as a medtech/orthotics platform company rather than a drug-development biotech.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on SubioMed.